You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunoscore

Showing 1 - 25 of 40
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Role of Immunoscore® in Stage II-III Colorectal Cancer

Recruiting
  • Colon Adenocarcinoma
  • Immunoscore Colon Test
  • Brasília, Distrito Federal, Brazil
  • +1 more
Jun 14, 2022

Non Metastatic Colorectal Cancer Trial in Marseille (IMMUNOSCORE®)

Recruiting
  • Non Metastatic Colorectal Cancer
  • IMMUNOSCORE®
  • Marseille, France
  • +1 more
Apr 12, 2022

Rectal Cancer Trial in Guangzhou (Sintilimab)

Recruiting
  • Rectal Cancer
  • Guangzhou, Guangdong, China
    Department of colorectal surgery, the Sixth Affiliated Hospital,
Jul 11, 2022

Colon Cancer Stage III Trial in Vienna (drug, device, other)

Not yet recruiting
  • Colon Cancer Stage III
  • Vienna, Austria
    Medical University of Vienna
Mar 26, 2022

NSCLC Trial in Denmark, Norway (Will look for immune infiltration)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Will look for immune infiltration
  • København, København Ø, Denmark
  • +4 more
Jan 6, 2022

The Immunoscore as a Prognostic Marker for a Colorectal Cancer

Active, not recruiting
  • Colorectal Cancer
  • Surgical Resection of the Colorectal Tumor
    • Besançon, France
    • +5 more
    Oct 11, 2021

    Stage II Colon Cancer, Adjuvant Chemo Trial (FOLFOX/XELOX/Capecitabine)

    Not yet recruiting
    • Stage II Colon Cancer
    • Adjuvant Chemotherapy
    • (no location specified)
    Apr 6, 2020

    Oral Leukoplakia, Oral Leukoplakia of Tongue, Oral Leukoplakia of Gingiva Trial in Erlangen

    Recruiting
    • Oral Leukoplakia
    • +3 more
      • Erlangen, Germany
        Universitätsklinikum Erlangen, FAU Erlangen-Nürnberg
      Dec 2, 2019

      Personalizing Colorectal Cancer Medicine (ImmuCol2)

      Active, not recruiting
      • Colon Cancer
        • Besançon, France
        • +8 more
        Oct 11, 2021

        Colonic Tumors Trial in France (Immunoscore Colon Test)

        Withdrawn
        • Colonic Neoplasms
        • Immunoscore Colon Test
        • Blois, France
        • +20 more
        Aug 27, 2019

        Colon Cancer Trial in San Antonio (PalloV-CC)

        Recruiting
        • Colon Cancer
        • PalloV-CC
        • San Antonio, Texas
          Clinical Associates of Research Therapeutics of America
        Sep 14, 2022

        NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • Phase I - Mirdametinib - Level 1
        • +4 more
        • (no location specified)
        Jul 7, 2023

        Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)

        Active, not recruiting
        • Rectal Adenocarcinoma
        • Portland, Oregon
          Providence Cancer Center
        Mar 22, 2022

        Colon Cancer Trial in Slagelse (Metformin Hydrochloride, Placebo oral capsule)

        Completed
        • Colon Cancer
        • Metformin Hydrochloride
        • Placebo oral capsule
        • Slagelse, Denmark
          Department of Surgery, Slagelse Hospital
        Mar 2, 2022

        Glioblastoma Multiforme of Brain Trial in Gatineau (avelumab)

        Completed
        • Glioblastoma Multiforme of Brain
        • avelumab
        • Gatineau, Quebec, Canada
          Clinique Neuro-Outaouais
        Jul 19, 2022

        Triple Negative Breast Cancer, Hormone Receptor Positive (HR+), HER2-negative Breast Cancer, Biopsy-proven, Positive Lymph

        Recruiting
        • Triple Negative Breast Cancer
        • +2 more
        • Radiation Therapy Boost
        • +6 more
        • Washington, District of Columbia
        • +8 more
        Dec 5, 2022

        Colorectal Tumors, Tumor Metastasis, Colonic Tumors Trial in Seoul (Atezolizumab, Bevacizumab, Oxaliplatin)

        Active, not recruiting
        • Colorectal Neoplasms
        • +3 more
        • Seoul, Songpa-gu, Korea, Republic of
          Asan Medical Center
        Jul 6, 2022

        Endometrial Serous Adenocarcinoma Trial in United States (Biospecimen Collection, Resection, Triapine)

        Recruiting
        • Endometrial Serous Adenocarcinoma
        • Biospecimen Collection
        • +2 more
        • Coral Gables, Florida
        • +5 more
        Aug 23, 2022

        Triple Negative Breast Cancer Trial in Washington, Chicago, Hackensack (Nivolumab, Capecitabine)

        Active, not recruiting
        • Triple Negative Breast Cancer
        • Washington, District of Columbia
        • +3 more
        Mar 14, 2022

        COLON-IM : Microbiota and Immune Infiltrate in Normal,

        Recruiting
        • Colorectal Cancer
          • Lyon, France
          • +1 more
          Jul 22, 2022

          Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Buffalo

          Active, not recruiting
          • Recurrent Fallopian Tube Carcinoma
          • +2 more
          • Aldesleukin
          • +4 more
          • Buffalo, New York
            Roswell Park Cancer Institute
          Mar 3, 2022

          Melanoma Trial in Italy (Cobimetinib 20 MG Oral Tablet, Vemurafenib 240 Mg Oral Capsule, Atezolizumab 1200 MG in 20 ML

          Recruiting
          • Melanoma
          • Cobimetinib 20 MG Oral Tablet
          • +2 more
          • Bagno A Ripoli, Firenze, Italy
          • +5 more
          Apr 12, 2022

          Immune Biomarker Study for Head and Neck Cancer

          Recruiting
          • Head and Neck Cancer
          • +4 more
          • Sampling
          • Erlangen, Bavaria, Germany
          • +2 more
          Jan 23, 2023

          Immunoscore in Rectal Cancer

          Completed
          • Cancer of the Rectum
          • +4 more
          • Diagnostic Biopsy and Surgical Procedure
          • +3 more
          • Portland, Oregon
          • +1 more
          Aug 27, 2018

          Metastatic Angiosarcoma, Metastatic Dedifferentiated Liposarcoma, Metastatic Osteosarcoma Trial in Houston (Durvalumab,

          Recruiting
          • Metastatic Angiosarcoma
          • +7 more
          • Durvalumab
          • Oleclumab
          • Houston, Texas
            M D Anderson Cancer Center
          Sep 21, 2021